Vagal Nerve Stimulation and Glucose Metabolism

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

November 30, 2012

Conditions
Type 2 DiabetesObesityGastric Emptying
Interventions
DEVICE

VNB on

The implanted Vagal Nerve Blocker will be on at the time of study.

DEVICE

VNB off

The implanted Vagal Nerve Blocker will be off at the time of study.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Mayo Clinic

OTHER